COVID-19
Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics
Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe
Thursday, May 28, 2020
